CMS revised a chapter in the Medicare Program Integrity Manual, which details policies and procedures for Medicare Administrative Contractors and provides guidance for stakeholder engagement. 1. The ...
The seven A/B Medicare Administrative Contractors (MACs) are withdrawing the local coverage determinations (LCDs) for skin substitute grafts/cellular and tissue-based products for the treatment of dia ...
CMS has announced updates to the process for making Medicare national coverage determinations (NCDs) to provide clarity and transparency with regard to modifications made to the coverage process since ...
The Centers for Medicare and Medicaid Services said this week it's opening a National Coverage Determination analysis, a process that will allow the agency to review and determine whether Medicare ...
Today, the Food & Drug Administration (FDA) will announce a decision on whether to approve the biologic aducanumab, intended to alleviate symptoms in patients with Alzheimer’s Disease. Currently, more ...
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and ...
Medicare will only cover Biogen Alzheimer’s disease drug Aduhelm for beneficiaries enrolled in a clinical trial, a decision that limits use of that product and also affects experimental medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback